Abstract Experimental models of mouse paw infection with L. amazonensis show an induction of a strong inflammatory response in the skin, and parasitic migration may occur to secondary organs with consequent tissue injury. There are few studies focusing on the resolution of damage in secondary organs caused by Leishmania species-related cutaneous leishmaniasis. We investigated the propolis treatment effect on liver inflammation induced by Leishmania amazonensis infection in the mouse paw. BALB/c mice were infected in the hind paw with L. amazonensis ( 10 7 ) promastigote forms. After 15 days, animals were treated daily with propolis (5 mg/ kg), Glucantime (10 mg/kg), or with propolis plus Glucantime combined. After 60 days, mice were euthanized and livers were collected for inflammatory process analysis. Liver microscopic analysis showed that propolis reduced the inflammatory process compared to untreated infected control. There was a decrease of liver myeloperoxidase and N-acetyl-β-glucosaminidase activity levels, collagen fiber deposition, pro-inflammatory cytokine production, and plasma aspartate transaminase and alanine transaminase levels. Furthermore, propolis treatment enhanced anti-inflammatory cytokine levels and reversed hepatosplenomegaly. Our data demonstrated that daily low doses of Brazilian propolis reduced the secondary chronic inflammatory process in the liver caused by L. amazonensis subcutaneous infection in a susceptible mice strain.
Introduction
Protozoa of the genus Leishmania are the causative agent of leishmaniasis, a neglected disease with high morbidity, mortality, and therapeutic failure, constituting a public health problem, and can cause skin lesions or visceral involvement (Grevelink and Lerner 1996; Desjeux 2004) . American cutaneous leishmaniasis is characterized by ulcerative skin lesions, localized or mucosal, and disseminated lesions (nonulcerated nodules) (Reithinger et al. 2007 ).
Leishmania amazonensis is one of the main etiologic agents responsible for cutaneous leishmaniasis in Brazil. This parasite may cause the localized or diffuse clinical forms of the disease, depending on the host immune response and parasitic virulence Jones et al. 2000; Ji et al. 2003) .
The classic lesions in cutaneous leishmaniasis are most often ulcerated lesions in the skin, with a granular base and raised borders (Bittencourt and Barral 1991) . However, in experimental infections with L. braziliensis, L. tropica, L. mexicana, L. major, and L. amazonensis, cases of migration to secondary organs differing from the site of infection have been described. These species were initially described as parasites with a unique tropism for skin and mucosa (Walton et al. 1977; Barral et al. 1986; Magill et al. 1993; Mohareb et al. 1996; Abreu-Silva et al. 2004; Wilson et al. 2005; Soliman 2006; Ribeiro-Romão et al. 2014 ). In addition, L. amazonensis has been reported as an etiologic agent of human visceral leishmaniasis (Roberts et al. 1989; Barral et al. 1991) .
Visceralization due to hematogenous dissemination via phagocytic cells such as monocytes has resulted to histological damage to lymph nodes, liver, spleen, and bone marrow (Duarte and Corbett 1987) . Splenomegaly is usually observed, with many macrophages parasitized by amastigotes. Liver disorders result from hypertrophy and hyperplasia of Kupffer cells, as well as intracellular fibrosis, and complications of fulminant hepatitis (Engwerda and Kaye 2000; Baranwal et al. 2007 ).
The host immune response is essential for disease control and elimination of the parasite, but an uncontrolled inflammatory response is a common mechanism involved in the majority of cases of clinical visceral leishmaniasis, resulting to secondary tissue damage with granulomatous changes and fibrosis (Gutierrez et al. 1984; Grevelink and Lerner 1996; Leite and Croft 1996; Nylén and Gautam 2010; Gupta et al. 2013) .
Propolis has been widely used in popular medical practice and has shown promising results in a range of experimental models, including activity against some trypanosomatids of medical importance. For instance, propolis kills promastigote and amastigote forms of varied Leishmania species (Machado et al. 2007; Ayres et al. 2007; Duran et al. 2008; Pontin et al. 2008; Ozbilge et al. 2010; Ayres et al. 2011; da Silva et al. 2013 ).
In addition, several studies have shown that propolis has anti-inflammatory properties and accelerates tissue regeneration as well as exhibits an antimicrobial action and shortens healing time (Barbosa et al. 2009; Khorasgani et al. 2010; Ikeda et al. 2011; Olczyk et al. 2013a, b) .
Studies have also demonstrated that the ethanolic extract of propolis has anti-inflammatory properties in both chronic and acute inflammation and exerts protective effects against hepatotoxicity (Seo et al. 2003; Batista et al. 2012) . The molecular mechanisms involved in the immunomodulatory and antiinflammatory activities of this natural compound include the capacity of inhibiting T cell activation by affecting mainly IL-2, NF-κB, MAP, STAT 3, and IL-6 (Okamoto et al. 2012; Búfalo et al. 2013) . Other studies have also reported a decrease in myeloperoxidase (MPO) and NADPH-oxidase activities (Frenkel et al. 1993; Volpert and Elstner 1996) and ornithine decarboxylase, tyrosine protein kinase, and hyaluronidase activities (Miyataka et al. 1997) .
Considering the antimicrobial and anti-inflammatory activity of propolis, the aim of the present study was to evaluate the effect of low dose propolis on liver inflammation in an experimental model of subcutaneous infection in a susceptible murine strain with L. amazonensis.
Materials and methods

L. amazonensis
L. amazonensis (MHOM/BR/1989/166MJO) was obtained from homogenate of popliteal lymph nodes of infected BALB/c mice. The promastigote forms were cultured in 199 medium (Invitrogen-GIBCO) and supplemented with 10 % fetal bovine serum (Invitrogen-GIBCO), 1 M Hepes, 0.1 % human urine, 0.1 % L-glutamine, 1 % penicillin/streptomycin solution (Invitrogen-GIBCO), and 10 % sodium bicarbonate. Cultures were incubated at 25°C in 25-cm 2 flasks. Promastigote forms, in stationary the growth phase (5 culture days), were used for experimental infection of the animals.
Propolis extract
The propolis sample was collected in the Beekeeping Section of Lageado Farm, UNESP, Botucatu Campus, Brazil, from honeybee (Apis mellifera L.) colonies. The method of extraction as well as the chemical composition has already been documented in previous studies, where propolis was analyzed by gas chromatography (GC), gas chromatography-mass spectrometry (GC-MS), and thin layer chromatography (TLC) (Sforcin 2007) . The final concentration of the ethanol solvent in the experiments did not exceed 0.1 %. It is noteworthy that we used the same batch of propolis extract in all experiments to avoid differences in the active products and solvents.
Animals and experimental infection
Male BALB/c mice (20-25 g), 4-6 weeks old, were obtained from the Fundação Osvaldo Cruz, FIOCRUZ, Curitiba, Brazil. Mice were kept under pathogen-free conditions and used according to protocols approved by the Ethics Committee of the Universidade Estadual de Londrina (protocol No. 09/11).
Mice were divided into five groups with eight animals each. The groups were (1) control group (without infection and without treatment); (2) infected control group (with infection and without treatment); (3) propolis group (with infection and treatment with propolis); (4) Glucantime group (received infection and treatment with Glucantime); (5) propolis + Glucantime group (received infection and treatment with propolis and Glucantime combined).
Mice 
AST and ALT levels
The levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were used as markers of hepatocellular damage and determined in blood plasma by a colorimetric assay using a diagnostic kit from Labtest Diagnóstica™ (Lagoa Santa, MG, Brazil) (Hohmann et al. 2013 ).
Liver histological analysis
The liver of each animal was removed, perfused with saline, and sectioned into standardized fragments. One of the fragments was fixed in Bouin's solution for 48 h. Subsequently, the tissue was subjected to routine histological processing to obtain 4-μm sections, which were stained with hematoxylineosin and examined by light microscopy (Olympus, Miami, FL, USA). The analysis was performed according to quality and quantitative parameters of inflammation.
Histological variation was classified according to the level of lesions found by the following criteria: no histological alteration (−); isolated inflammatory foci, presence of up to 1 intralobular granuloma, and up to 5 Kupffer cells per microscopic field (+); isolated or coalescent area of histological changes including inflammation, 2-4 intralobular granulomas, and 5-10 Kupffer cells per field (++); disseminated histological changes including inflammation, over 4 intralobular granulomas, and 10 Kupffer cells per field (+++).
Hepatic fibrosis analysis
Collagen quantification was determined in Sirius red-stained liver sections under polarized light using a photomicroscope (CARL ZEISS Axio imager A1) with a camera (HBO 100) coupled to a computer using AxioVision software, at a final magnification of 200×. Eight images of four sections from each mouse were considered for the study and analyzed by Image Pro Plus (version 4.5). The results were expressed as the mean of area with presence of total collagen and percentage of area with type I and III collagen.
Myeloperoxidase activity and N-acetylglucosaminidase activity
Neutrophil migration to the liver was evaluated by the MPO kinetic-colorimetric assay. N-acetylglucosaminidase (NAG) assay was used for evaluating the infiltration of macrophages in the liver. Samples were collected in 50 mM K 2 PO 4 buffer (pH 6.0) containing 0.5 % HTAB and were homogenized using a Polytron® (PT3100).
After the homogenates were centrifuged (16,100 × g, 2 min, 4°C), the resulting supernatant was assayed spectrophotometrically for MPO or NAG activity at 450 nm (Spectra max) with three readings within 1 min. MPO activity of the samples was compared with a standard curve of neutrophils, and MPO activity results were presented as the number of neutrophils × 10 4 /mg of tissue. NAG activity in the samples was compared with a standard curve of macrophages, and NAG activity results were presented as the number of macrophages × 10 3 /mg of tissue) (Hohmann et al. 2013 ).
Cytokine measurement
Cytokines present in liver fragments were analyzed by enzyme-linked immunosorbent assay (ELISA). Samples were homogenized in 500 μL of buffer containing protease inhibitors (1 mM Phenylmethanesulfonyl fluoride, Sigma Aldrich), and IFN-γ, TNF-α, IL-17, IL-6, IL-12, IL-10, TGF-β, and IL-13 levels were determined by ELISA, according to the manufacturer's instructions (eBiosciences®, USA). Plates were read at 450 nm, using an ELISA plate reader (Thermo Plate-TP-Reader). Results were expressed as pg cytokine/ mg tissue.
Statistic analysis
Data were analyzed using GraphPad Prism statistical software (GraphPad Software, Inc., USA-500.288, version 5.0). Significant differences between treatments were determined by ANOVA, followed by Tukey's test for multiple comparisons. Statistical significance was accepted when P < 0.05.
Results
Effect of propolis extract on blood plasma levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) and weight of liver and spleen Blood samples were collected after 60 days of treatment for the assessment of AST/ALT levels. The infection with L. amazonensis induced a significant increase in AST (Fig. 1a) and ALT (Fig. 1b) levels. These enzyme levels were reduced by propolis or by its combination with Glucantime by 85 and 87 %, respectively.
Liver and spleen weights increased after 75 days of infection (Fig. 2a, b) . Data showed that the liver and spleen of animals treated with propolis alone or combined with Glucantime did not differ when compared with the uninfected group (Fig. 2a, b) . However, the weight of the liver and spleen of animals treated with propolis or propolis and Glucantime combined decreased when compared to infected control (Fig. 2a, b) .
The liver and spleen weights of animals treated with Glucantime alone were significantly increased compared to infected control animals (Fig. 2a, b) .
Propolis promoted an anti-inflammatory effect in liver reducing granuloma formation and deposition of type I and III collagen fibers
The liver sample collected for histological analysis showed that L. amazonensis infection (10 7 /20 μL/paw, s.c injection) induced histological changes. These alterations included increased infiltration of Kupffer cells, intralobular granuloma formation, and inflammation in the portal tracts (Fig. 3a-c) . These changes were classified as disseminated histological changes (+++), which were reduced after treatment with 5 mg/kg propolis, classified as isolated inflammatory foci (+ ). Glucantime also reduced the changes in liver tissue to a level classified as isolated or coalescent area of histological changes (++). Glucantime in combination with propolis resulted in isolated inflammatory foci (+) ( Table 1) .
Infection induced the deposition of collagen fibers type I and III (Fig. 4a) . Treatment with propolis, Glucantime, and the two combined reduced the deposition of total collagen fibers when compared with the infected control group (Fig. 4a) .
The prevalence of type III collagen fibers was seen in all groups (Fig. 4b) . Type I collagen fibers appeared less than 15.53 % in the control group without infection and in groups treated with propolis and propolis combined with Glucantime (Fig. 4b) . The percentage of this type collagen fiber in infected control and Glucantime-treated groups was 35.38 and 28.18 %, respectively (Fig. 4b) .
Propolis reduced L. amazonensis-induced myeloperoxidase and n-acetylglucosaminidase activities in liver tissue
After 60 days of treatment, the liver samples were collected for evaluation of MPO and NAG activities. L. amazonensis infection induced a significant increase in MPO (Fig. 5a ) and NAG (Fig. 5b) compared to control. Treatment with propolis decreased MPO activity by 27 % and NAG activity by 31 % compared with infected control. Combined treatment also produced similar changes in enzyme activity.
Propolis reduced L. amazonensis-induced IFN-γ, TNF-α, IL-17, and IL-6 production and increased production of anti-inflammatory cytokines in the liver After 60 days of treatment, liver samples were collected for the assessment of cytokine production. L. amazonensis infection increased the production of IFN-γ, TNF-α, IL-17, and IL-6 in liver (Fig. 6a-d) . However, these levels were reduced by treatment with 5 mg/kg propolis ( Fig. 6a-d) . On the other hand, propolis increased IL-10, TGF-β, and IL-13 production (Fig. 7a-c) and did not affect IL-12 production (Fig. 6e) . Furthermore, propolis combined with Glucantime also enhanced the production of IL-10 and IL-13 (Fig. 7a, c) and reduced TNF-α, IL-17, and IL-6 production when compared to infected control (Fig. 6b-d ).
Discussion
In this study, L. amazonensis infection in the paw spreads to other tissues such as the liver. There are histological changes in the liver including inflammation of the portal tract, hyperplasia, and hypertrophy of Kupffer cells and fibrosis. These histological changes were corroborated by the increase in MPO and NAG activities as well as by increased levels of the pro-inflammatory cytokines IFN-γ, TNF-α, IL-17, and IL-6 in the liver. Moreover, liver injury was associated with the classic increase in AST and ALT levels in the blood and hepatosplenomegaly. Importantly, treatment with propolis in a therapeutic protocol reduced all liver inflammatory responses induced by L. amazonensis paw infection.
Similar to the present murine model, there are morphological changes in the liver during human visceral leishmaniasis, characterized mainly by hypertrophy and hyperplasia of Kupffer cells with granuloma formation and intralobular portal and diffuse intralobular fibrosis (Murray 2001) .
It is known that wound healing response accounts for liver fibrosis in varied acute and chronic conditions. Liver fibrosis may occur due to increased synthesis and deposition of collagen (Friedman 2008) .
Few studies have demonstrated the importance of the liver fibrosis process in murine models of experimental infection with Leishmania. However, it is known that infection with L. donovani in BALB/c causes an increase in the deposition of collagen, particularly type III, in granuloma formation regions (Leite and Croft 1996) .
Liver fibrosis involves qualitative and quantitative changes in the composition of the extracellular matrix in the portal and sinusoidal space and is characterized by substantial deposition of fibrillar type I and III collagen, proteoglycans, fibronectin, and hyaluronic acid in the scar regions (George and Chandrakasan 1996; George et al. 2004; Zeisberg et al. 2006) . Interleukin-13 is associated with inducing fibrosis in chronic infectious and autoimmune diseases like schistosomiasis and chronic asthma. However, the pathogenesis of fibrous tissue involves IL-13 associated with a cascade of events that involve an increase of TGF-β and TNF-α, regulating collagen synthesis and collagen catabolism (Wynn 2004; FichtnerFeigl et al. 2006 ).
In our study, the Sirius red staining method with polarized light microscopy was used, allowing the characterization of type I and III of collagen in tissues. Three colors can be distinguished: green, characteristic of thin collagen fibers and reticular type III, and the yellow to red spectrum, indicating dense type I fibers (Montes and Junqueira 1991) . Thus, it was possible to evaluate the total collagen Some authors suggest that oxidative stress also participates in the process of fibrosis, which can progress to necrosis or apoptosis of hepatocytes. The increase in pro-fibrogenic response with consequent increased expression and deposition of type I collagen fibers may be evidenced by reduction of antioxidant defenses such as glutathione (GSH), catalase, or superoxide dismutase (SOD), along with an increase in lipid peroxidation (George 2003; Bataller and Brenner 2005; Nieto 2006 ).
Propolis-treated groups showed reduced chronic inflammation, with a decrease in the deposition of type I and III collagen; lower levels of the pro-inflammatory cytokines TNF-α, IL-17, and IL-6; decreased AST and ALT levels; and reduction in liver and spleen weights.
Hepatosplenomegaly is another important factor observed as a clinical sign in visceral leishmaniasis. Thus, to evaluate possible changes resulting from infection or treatment, the liver and spleen weights of the animals were evaluated. L. amazonensis infection increased liver and spleen weights. However, the treatment with propolis with or without Glucantime reversed this process.
Previous studies with different propolis extracts have shown antiprotozoal activity, as well as immunomodulatory and anti-inflammatory effects (Dimov et al. 1992; Ramos and Miranda 2007; Ayres et al. 2007; Sforcin 2007; da Silva et al. 2013) . In addition, the wound healing activity of propolis has attracted attention (Olczyk et al. 2013a, b) .
The sample of Brazilian propolis used in our experiments has exhibited leishmanicidal, fungicidal, antimicrobial, and immunomodulatory effects in different experimental models (Orsi et al. 2000 (Orsi et al. , 2012 Murad et al. 2002; Sforcin 2007; Missima and Sforcin 2008; da Silva et al. 2013; Miranda et al. 2015) . Some studies have suggested that the immunomodulatory action of propolis may occur through the inhibition of T cell activation by inhibiting mainly IL-2, NF-κB, MAPK, STAT 3, and IL-6. In addition, other studies have shown a decrease in MPO and NADPH-oxidase activities (Frenkel et al. 1993; Volpert and Elstner 1996; Okamoto et al. 2012; Búfalo et al. 2013) .
The available drug in Brazil for the treatment of leishmaniasis is an antimonial, a complex of Sb (V) with N-methyl-Dglucamine (meglumine antimoniate or Glucantime®). However, this drug has serious side effects and limitations in its use and shows therapeutic failures (Sundar and Chakravarty 2013) .
Here, we found that animals treated with Glucantime did not show an improvement of inflammatory responses induced by infection with L. amazonensis. However, when Glucantime was combined with propolis, the anti-inflammatory effects became more evident. Furthermore, studies have suggested the use of propolis combined with Glucantime to decrease the side effects of Glucantime in the host (Ayres et al. 2011; Ferreira et al. 2014) .
Considering the antioxidant and anti-inflammatory role that propolis has shown in several models, our data indicated that the daily treatment in mice susceptible to infection with L. amazonensis is able to prevent the progression of lesions in the liver. This effect may be due to immunomodulatory effects with consequent reduction of inflammatory infiltrate, granuloma formation, and fibrosis in liver tissue.
Conclusion
Our study demonstrated the anti-inflammatory effect of propolis in the liver, when given at low daily doses. Propolis promoted immunomodulation with efficacy by reducing cellular recruitment, which prevented inflammatory processes in the liver due to infection with L. amazonensis. Furthermore, these data encourage further studies to determine the value of combining this apitherapeutic agent with Glucantime to increase the treatment efficacy in leishmaniasis and reduce the side effects of Glucantime. 
